Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-12T05:21:58.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A minor revision tag was updated from v3.4.0 to v3.4.1; there is no evidence of substantive changes to study content or function. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T03:49:21.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated metadata with Revision: v3.4.0, including capitalization changes to QC status labels. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-29T00:00:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 label on the page. This is a minor technical update and does not change study details or content.
    Difference
    0.0%
    Check dated 2026-01-14T01:54:44.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations were updated to add new sites across the US, South Africa, Brazil, and Thailand, and some location entries were removed or reorganized (v3.3.3).
    Difference
    1%
    Check dated 2025-12-23T09:21:34.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.3.2 and a removal of Revision: v3.3.1, indicating a minor administrative update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:49:55.000Z thumbnail image

Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.